Skip to main content

OPINION article

Front. Med.
Sec. Gene and Cell Therapy
Volume 11 - 2024 | doi: 10.3389/fmed.2024.1463997
This article is part of the Research Topic Emerging Evidence of Cell-Based Therapies for Non-malignant and Non-genetic Diseases View all 3 articles

Injection Therapy in Knee Osteoarthritis: Cortisol or Hyaluronic acid or PRP or BMAC (mesenchymal stem cell therapy)?

Provisionally accepted
Christof Pabinger Christof Pabinger 1*Georg S. Kobinia Georg S. Kobinia 1Dietmar Dammerer Dietmar Dammerer 2
  • 1 Institute for Regenerative Medicine, Austria, Graz, Austria
  • 2 Karl Landsteiner University of Health Sciences, Krems an der Donau, Lower Austria, Austria

The final, formatted version of the article will be published soon.

    Keywords: Arthritis, OA, Osteoarthritis, Knee, BMA, Mesenchymal Stem Cells, Hyaluronic Acid, PRP

    Received: 12 Jul 2024; Accepted: 23 Aug 2024.

    Copyright: © 2024 Pabinger, Kobinia and Dammerer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Christof Pabinger, Institute for Regenerative Medicine, Austria, Graz, Austria

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.